Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -91.7% | -164.3% | 0 / 3 | -62.1% | +0.94 pp | -1.30 pp | -1.1% | 0.35 | — | 232 | −62,1% | 0,5 | −94,4% | — | 11.85 | — |
| Pts | 0 | 0 | 0 | 0 | 8 | 4 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 3.150 (close price on 2026-10-19)EPS (TTM): −135,6
Financial charts
1.Revenue & growth
VND bn232Q2/26
1.Revenue & growth
VND bn232Q2/26
2.Profit & growth
VND bn0,87Q2/26
3.Profit mix (Penman)
VND bn-1,33Q2/26
4.Margins & cost structure
%12.5%Q2/26
5.Returns & cash cycle
% · days0.1%Q2/26
6.Earnings quality & cash
VND bn-118Q2/26
7.Asset structure
VND bn636Q2/26
8.Funding & debt health
VND bn · times636Q2/26
9.Revenue backlog
VND bn19,0Q2/26
10.Valuation
times · %-36,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %36Q2/26
Adjusted EPS growth, latest quarter
-91.5%
Average adjusted EPS growth, 3 quarters
-75.7%
averaged over 2 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26